Solstice Advanced Materials hides a mispriced uranium conversion monopoly. It owns Metropolis Works, the only US plant, with 20% of world UF6 supply. Old $20/kgU contracts roll off through 2028 versus $64 spot; almost all of that reset hits EBIT. Buried in specialty materials, it trades near 7.5x EBITDA versus 60x for Centrus and 70x for Cameco. Conversion alone could be worth $15B+ by 2028: $150 a share at 21x, $325-370 at peer multiples. Base case: $110-135 by end-2026, $155-190 by end-2027. x.com x.com x.com x.comÂ
